A recent study published in eLife offers a new perspective on the development of Alzheimer’s disease, suggesting that the ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study. For several decades, researchers studying Alzheimer's disease have been working to ...

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an anaesthetic since the early 1950s and, more recently, to treat brain ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

Prolonged rapid eye movement (REM) sleep latency was linked with Alzheimer's disease biomarkers, cross-sectional data showed.

Amyloidosis is a group of diseases characterized ... and have systems in place to gain human feedback on the overall quality of the process. We however cannot guarantee the accuracy of every ...